Susquehanna International Group, LLP Exelixis, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Exelixis, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 69,447 shares of EXEL stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,447

Previous 101,028 31.26%

Holding current value

$1.83 Million

Previous $2.4 Million 34.92%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$20.34 - $23.73 $642,357 - $749,417	-31,581 Reduced 31.26%	69,447 $1.56 Million
Q1 2024 May 07, 2024	SELL	$20.17 - $23.93 $1.67 Million - $1.98 Million	-82,882 Reduced 45.07%	101,028 $2.4 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $10 Million - $12.6 Million	-521,288 Reduced 73.92%	183,910 $4.41 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $1.69 Million - $2.02 Million	-88,787 Reduced 11.18%	705,198 $15.4 Million
Q2 2023 Aug 11, 2023	BUY	$18.17 - $20.48 $816,977 - $920,842	44,963 Added 6.0%	793,985 $15.2 Million
Q1 2023 May 16, 2023	BUY	$16.3 - $19.41 $9.98 Million - $11.9 Million	612,505 Added 448.67%	749,022 $14.5 Million
Q4 2022 Feb 14, 2023	SELL	$14.96 - $17.39 $1.51 Million - $1.75 Million	-100,671 Reduced 42.44%	136,517 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $222,358 - $315,810	14,181 Added 6.36%	237,188 $3.72 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $504,277 - $669,671	28,915 Added 14.9%	223,007 $4.64 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $3.22 Million - $4.28 Million	-188,958 Reduced 49.33%	194,092 $4.4 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $336,520 - $464,840	21,245 Added 5.87%	383,050 $7 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $21.14 $773,500 - $1 Million	-47,454 Reduced 11.6%	361,805 $7.65 Million
Q2 2021 Aug 11, 2021	BUY	$17.95 - $25.56 $1.17 Million - $1.66 Million	64,970 Added 18.87%	409,259 $7.46 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $3.15 Million - $3.87 Million	-153,471 Reduced 30.83%	344,289 $7.78 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $2.6 Million - $3.5 Million	-141,243 Reduced 22.1%	497,760 $9.99 Million
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $4.25 Million - $5.54 Million	205,584 Added 47.43%	639,003 $15.6 Million
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $2.62 Million - $4.37 Million	-159,417 Reduced 26.89%	433,419 $10.3 Million
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $2.11 Million - $3.18 Million	-146,040 Reduced 19.77%	592,836 $10.2 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $19 Million - $23.7 Million	-1,252,653 Reduced 62.9%	738,876 $13 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $10.5 Million - $13.4 Million	-592,482 Reduced 22.93%	1,991,529 $35.2 Million
Q2 2019 Aug 16, 2019	BUY	$18.93 - $24.75 $628,513 - $821,749	33,202 Added 1.3%	2,584,011 $55.2 Million
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $7.23 Million - $9.46 Million	382,061 Added 17.62%	2,550,809 $54.5 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $3.63 Million - $4.58 Million	185,143 Added 9.33%	2,168,748 $51.6 Million
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $8.59 Million - $13.7 Million	629,369 Added 46.47%	1,983,605 $39 Million
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $17.1 Million - $24.1 Million	1,077,338 Added 389.07%	1,354,236 $24 Million
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $30.7 Million - $37.1 Million	-1,654,497 Reduced 85.66%	276,898 $5.96 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $13.1 Million - $18.9 Million	593,053 Added 44.31%	1,931,395 $42.8 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $26.8 Million - $34.3 Million	1,108,027 Added 481.09%	1,338,342 $40.7 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $5.38 Million - $6.73 Million	230,315	230,315 $5.58 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

240M

Call Options Held

2.04M

Put Options Held

1.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $8.46B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Exelixis, Inc. Transaction History